Cargando…

Zebrafish ProVEGF-C Expression, Proteolytic Processing and Inhibitory Effect of Unprocessed ProVEGF-C during Fin Regeneration

BACKGROUND: In zebrafish, vascular endothelial growth factor-C precursor (proVEGF-C) processing occurs within the dibasic motif HSIIRR(214) suggesting the involvement of one or more basic amino acid-specific proprotein convertases (PCs) in this process. In the present study, we examined zebrafish pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khatib, Abdel-Majid, Lahlil, Rachid, Scamuffa, Nathalie, Akimenko, Marie-Andrée, Ernest, Sylvain, Lomri, Abdderahim, Lalou, Claude, Seidah, Nabil G., Villoutreix, Bruno O., Calvo, Fabien, Siegfried, Geraldine
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2896389/ https://www.ncbi.nlm.nih.gov/pubmed/20625388 http://dx.doi.org/10.1371/journal.pone.0011438

Ejemplares similares

A Novel Enediynyl Peptide Inhibitor of Furin That Blocks Processing of proPDGF-A, B and proVEGF-C
por: Basak, Ajoy, et al.
Publicado: (2009)

The therapeutic response in Gorham’s syndrome to the beta-blocking agent propranolol is correlated to VEGF-A, but not to VEGF-C or FLT1 expression
por: Baud, Jessica, et al.
Publicado: (2015)

Proteolytic Cleavages in the VEGF Family: Generating Diversity among Angiogenic VEGFs, Essential for the Activation of Lymphangiogenic VEGFs
por: Künnapuu, Jaana, et al.
Publicado: (2021)

Effects of fin fold mesenchyme ablation on fin development in zebrafish
por: Lalonde, Robert L., et al.
Publicado: (2018)

Pro- and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy
por: Paine, Suman K., et al.
Publicado: (2017)

Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies
por: Guyot, Mélanie, et al.
Publicado: (2016)

The Ionophoric Activity of a Pro-Apoptotic VEGF165 Fragment on HUVEC Cells
por: Zimbone, Stefania, et al.
Publicado: (2020)

Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-D
por: McColl, Bradley K., et al.
Publicado: (2003)

Allosteric regulation of Senecavirus A 3C(pro) proteolytic activity by an endogenous phospholipid
por: Zhao, Hai-Fan, et al.
Publicado: (2023)

VEGF(165)b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
por: Varey, A H R, et al.
Publicado: (2008)

KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D
por: Jha, Sawan Kumar, et al.
Publicado: (2019)

Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells
por: Timoshenko, A V, et al.
Publicado: (2007)

Intermittent hypoxia alleviates increased VEGF and pro-angiogenic potential in liver cancer cells
por: Dong, Gang, et al.
Publicado: (2019)

Quantifying the Proteolytic Release of Extracellular Matrix-Sequestered VEGF with a Computational Model
por: Vempati, Prakash, et al.
Publicado: (2010)

DNA methylation regulates expression of VEGF-C, and S-adenosylmethionine is effective for VEGF-C methylation and for inhibiting cancer growth
por: Da, M.X., et al.
Publicado: (2014)

The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A
por: Dedieu, S, et al.
Publicado: (2010)

Glioblastoma stem-like cells secrete the pro-angiogenic VEGF-A factor in extracellular vesicles
por: Treps, Lucas, et al.
Publicado: (2017)

Non-proteolytic calpain-6 interacts with VEGFA and promotes angiogenesis by increasing VEGF secretion
por: Oh, Mijung, et al.
Publicado: (2019)

Bioactive VEGF-C from E. coli
por: Rauniyar, Khushbu, et al.
Publicado: (2022)

Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1
por: Jha, Sawan Kumar, et al.
Publicado: (2017)

Complex formation of anti‐VEGF‐C with VEGF‐C released during blood coagulation resulted in an artifact in its serum pharmacokinetics
por: Bumbaca Yadav, Daniela, et al.
Publicado: (2020)

Discovery of the Proprotein Convertases and their Inhibitors
por: Khatib, Abdel-Majid, et al.
Publicado: (2006)

Asiatic Acid Inhibits Pro-Angiogenic Effects of VEGF and Human Gliomas in Endothelial Cell Culture Models
por: Kavitha, Chandagirikoppal V., et al.
Publicado: (2011)

Hemodialysis exacerbates proteolytic imbalance and pro-fibrotic platelet dysfunction
por: Velasquez-Mao, Aaron J., et al.
Publicado: (2021)

VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
por: Ohta, Y, et al.
Publicado: (1999)

VEGF-C Is a Thyroid Marker of Malignancy Superior to VEGF-A in the Differential Diagnostics of Thyroid Lesions
por: Woliński, Kosma, et al.
Publicado: (2016)

Lymphangiogenesis in Gastric Cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis
por: Chen, Hongxia, et al.
Publicado: (2015)

Associations of nm23H1, VEGF-C, and VEGF-3 Receptor in Human Prostate Cancer
por: Yang, Zui-Su, et al.
Publicado: (2014)

Alginate hydrogels allow for bioactive and sustained release of VEGF-C and VEGF-D for lymphangiogenic therapeutic applications
por: Campbell, Kevin T., et al.
Publicado: (2017)

Glycation of fibronectin inhibits VEGF‐induced angiogenesis by uncoupling VEGF receptor‐2‐c‐Src crosstalk
por: Chen, Tangting, et al.
Publicado: (2020)

VEGF-A, VEGF-C, VEGF-R2, EGFR and HER2 in serum plus EGFR in tissue of patients with triple-negative breast cancer
por: Iosifidou, R, et al.
Publicado: (2009)

VEGF111b, a C-terminal splice variant of VEGF-A and induced by mitomycin C, inhibits ovarian cancer growth
por: Li, Xiuli, et al.
Publicado: (2015)

FinO/ProQ-family proteins: an evolutionary perspective
por: Liao, Zhen, et al.
Publicado: (2023)

Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer
por: Zajkowska, Monika, et al.
Publicado: (2018)

Elevated IGFIR expression regulating VEGF and VEGF-C predicts lymph node metastasis in human colorectal cancer
por: Zhang, Chunhui, et al.
Publicado: (2010)

CXCL7-Mediated Stimulation of Lymphangiogenic Factors VEGF-C, VEGF-D in Human Breast Cancer Cells
por: Yu, Minghuan, et al.
Publicado: (2010)

Distinct Characteristics of VEGF‐D and VEGF‐C to Predict Mortality in Patients With Suspected or Known Coronary Artery Disease
por: Wada, Hiromichi, et al.
Publicado: (2020)

Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment
por: Wecker, Thomas, et al.
Publicado: (2019)

Role of NO/cGMP signalling in VEGF-mediated angiogenesis
por: Jäger, Ronald, et al.
Publicado: (2011)

VEGF-independent angiogenic pathways induced by PDGF-C
por: Li, Xuri, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_rgsqrk9v5u8dj03c05v0ve9b53